Table 1 Association of HNF1A-AS1 expression (ΔCt) with clinicopathological features of patients

Age (years)

0.119

 ≥60

82(50.9)

16.17 ± 2.90

 <60

79(49.1)

15.47 ± 2.71

Gender

0.688

 Male

123(76.4)

15.78 ± 2.88

 Female

38(23.6)

15.99 ± 2.66

Tumor location

0.560

 Sinuses ventriculi

57(35.4)

16.06 ± 3.13

 Cardia

33(20.5)

15.87 ± 3.04

 Corpora ventriculi

45(28.0)

15.92 ± 2.50

 Others

26(16.1)

15.11 ± 2.36

Diameter(cm)

0.002

 ≥5

73(45.3)

16.59 ± 2.8

 <5

88(54.7)

15.2 ± 2.70

Differentiation

0.396

 Well

2(1.2)

16.15 ± 0.71

 Moderate

34(21.1)

15.24 ± 2.66

 Poor

125(77.7)

15.98 ± 2.87

Invasion

0.032

 T1

13(8.1)

16.13 ± 1.95

 T2

14(8.7)

14.09 ± 2.24

 T3

16(9.9)

14.85 ± 3.71

 T4

118(73.3)

16.13 ± 2.76

Lymphatic metastasis

0.006

 N0

38(23.6)

14.74 ± 2.77

 N1-3

123(76.4)

16.16 ± 2.76

Venous invasion

0.001

 Absent

86(53.4)

15.14 ± 2.58

 Present

75(46.6)

16.61 ± 2.90

Perineural invasion (PNI)

0.014

 Absent

89(55.3)

15.34 ± 2.77

 Present

72(44.7)

16.43 ± 2.79

CEA

0.028

 Normal

130(80.7)

15.59 ± 2.74

 High

31(19.3)

16.83 ± 2.97

CA19-9

0.009

 Normal

140(87.0)

15.60 ± 2.70

 High

21(13.0)

17.32 ± 3.22

AFP

0.936

 Normal

150(93.2)

15.82 ± 2.80

 High

11(6.8)

15.89 ± 3.25

CA-125

0.494

 Normal

154(95.7)

15.79 ± 2.84

 High

7(4.3)

16.55 ± 2.33